References
Schurch B et al. (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692–697
Reitz A et al. (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45: 510–515
Popat R et al. (2005) A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174: 984–988
Grosse J et al. (2005) Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47: 653–659
Harper M et al. (2003) A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 92: 325–326
Acknowledgements
The synopsis was written by Sandra Michelmore, Associate Editor, Nature Clinical Practice. The authors are supported by project grants from the British Urological Foundation (AS) and the Multiple Sclerosis Society (PD).
Author information
Authors and Affiliations
Author notes
Arun Sahai and Prokar Dasgupta: A Sahai is a Research Fellow and P Dasgupta a Consultant Urological Surgeon and Hon. Senior Lecturer
Corresponding author
Ethics declarations
Competing interests
The authors are co-investigators for Allergan, from whom they have received an unrestricted educational grant.
Rights and permissions
About this article
Cite this article
Sahai, A., Dasgupta, P. Is botulinum toxin type A a safe and effective treatment for neurogenic urinary incontinence?. Nat Rev Urol 2, 530–531 (2005). https://doi.org/10.1038/ncpuro0329
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0329
- Springer Nature Limited